Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 132

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 8
Chunk 132
---
Advertising and marketing123,926 21,135 145,061 Contribution margin$408,004 $72,229 480,233 Other operating expenses**502,648 Operating loss$(22,415)*Intersegment revenues of $4.3 million were eliminated from the North American OTC Healthcare segment.**Other operating expenses for the year ended March 31, 2023 includes a tradename impairment charge of $321.4 million and a goodwill impairment charge of $48.8 million.The tables below summarize information about our segment revenues from similar product groups.Year Ended March 31, 2025(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedAnalgesics$112,173 $5,524 $117,697 Cough & Cold82,533 23,681 106,214 Women's Health216,335 20,496 236,831 Gastrointestinal174,891 81,052 255,943 Eye & Ear Care158,858 24,464 183,322 Dermatologicals120,770 8,177 128,947 Oral Care81,868 13,162 95,030 Other OTC12,582 1,196 13,778 Total segment revenues$960,010 $177,752 $1,137,762 Year Ended March 31, 2024(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedAnalgesics$111,996 $5,455 $117,451 Cough & Cold93,575 25,445 119,020 Women's Health217,103 23,318 240,421 Gastrointestinal160,889 70,721 231,610 Eye & Ear Care156,553 22,870 179,423 Dermatologicals123,288 5,814 129,102 Oral Care83,212 13,093 96,305 Other OTC11,644 381 12,025 Total segment revenues$958,260 $167,097 $1,125,357 

77

Year Ended March 31, 2023(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedAnalgesics$116,582 $2,680 $119,262 C